...
机译:Rituximab治疗与儿童类固醇抗性肾病综合征的甲基己酮脉冲治疗和免疫抑制剂相结合
Department of Nephrology and Rheumatology National Center for Child Health and Development 2-10-1;
Department of Nephrology and Rheumatology National Center for Child Health and Development 2-10-1;
Department of Nephrology and Rheumatology National Center for Child Health and Development 2-10-1;
Department of Nephrology and Rheumatology National Center for Child Health and Development 2-10-1;
Department of Nephrology and Rheumatology National Center for Child Health and Development 2-10-1;
Department of Pediatrics Tohoku University School of Medicine Miyagi Japan;
Department of Pediatrics Kobe University Graduate School of Medicine Hyogo Japan;
Department of Pediatrics Kobe University Graduate School of Medicine Hyogo Japan;
Department of Nephrology and Rheumatology National Center for Child Health and Development 2-10-1;
B cell; Immunosuppressive agents; Methylprednisolone pulse therapy; Rituximab; Steroid-resistantnephrotic syndrome;
机译:利妥昔单抗联合甲基强的松龙脉冲疗法和免疫抑制剂治疗儿童类固醇抵抗性肾病综合征
机译:甲基强的松龙脉冲疗法在类固醇抵抗性肾病综合征中的疗效。
机译:利妥昔单抗输注后大剂量泼尼松龙的再次治疗,用于儿童期激素抵抗性肾病综合征
机译:VAD化疗,然后是自体干细胞移植(ASCT)用于在轻链(Al)淀粉样蛋白症中治疗肾病综合征
机译:获得性利妥昔单抗耐药性与对化疗的交叉耐药性相关,而硼替佐米治疗可以克服这种交叉耐药性。
机译:研究方案:利妥昔单抗治疗后的霉酚酸酯作为儿童期发作的复杂的经常复发的肾病综合征或类固醇依赖性肾病综合征的维持疗法:一项多中心双盲随机安慰剂对照试验(JSKDC07)
机译:抗类固醇肾病综合征的脉冲血管肽治疗